Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
AuthAuth
1 day ago
|
parent
|
context
|
favorite
| on:
Goldman Sachs asks in biotech Report: Is curing pa...
It shouldnt be limited to companies within the country. Any foreign company can be a market disruptor here. Assuming the drug approval admin isnt working alongside the 'cartel'.
ComplexSystems
22 hours ago
|
next
[–]
And only in the very particular scenario of a national-only cartel which has not successfully roped in other international pharma companies.
reply
zdc1
1 day ago
|
prev
[–]
And then there's medical tourism, for the people who prefer to shop at one of the other 'cartels'
reply
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search: